Home / Western and Central Africa / LBR

Liberia

Liberia appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. PEPFAR's results for the country are broken down by province and count only the sites PEPFAR supports. The assessment of national sources, country by country, is set out on the Methods page.

56,000

People living with HIV, 2025

WHO Global Health Observatory

59.0%

On antiretroviral treatment, 2025

WHO Global Health Observatory

$10.0m

United States HIV disbursements, 2026

ForeignAssistance.gov

$24.9m

External HIV financing, all donors, 2024

OECD Creditor Reporting System

External HIV financing

OECD CRS · ForeignAssistance.gov

All donors
United States, OECD record
The Global Fund
United States, self-reported

Year	All donors	United States, OECD record	The Global Fund	United States, self-reported
2002	$65k	—	—	—
2003	$412k	—	—	—
2004	$1.8m	—	$1.3m	—
2005	$4.7m	—	$3.7m	—
2006	$4.2m	$530k	$2.7m	$6k
2007	$7.7m	$914k	$4.4m	$1.4m
2008	$7.4m	$1.1m	$5.3m	$1.1m
2009	$5.1m	$1.9m	—	$1.9m
2010	$15.3m	$3.2m	$10.0m	$2.8m
2011	$16.7m	$3.4m	$11.6m	$3.1m
2012	$14.8m	$5.1m	$8.2m	$5.1m
2013	$19.1m	$5.9m	$12.1m	$6.1m
2014	$7.2m	$2.7m	$3.6m	$3.0m
2015	$8.6m	$2.5m	$5.0m	$2.1m
2016	$8.2m	$2.5m	$4.6m	$3.2m
2017	$6.5m	$4.1m	$1.3m	$4.6m
2018	$6.1m	$3.7m	$1.8m	$3.6m
2019	$5.4m	$3.1m	$1.6m	$2.5m
2020	$17.2m	$3.6m	$11.6m	$3.1m
2021	$22.4m	$8.3m	$13.4m	$-1.1m
2022	$21.2m	$8.3m	$11.7m	$10.8m
2023	$27.2m	$7.5m	$19.5m	$8.8m
2024	$24.9m	$6.3m	$18.5m	$7.2m
2025	—	—	—	$9.7m
2026	—	—	—	$10.0m

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment

UNAIDS AIDSinfo

People living with HIV
People on treatment

Year	People living with HIV	People living with HIV (lower)	People living with HIV (upper)	People on treatment
2000	49,000	41,000	60,000	—
2001	49,000	42,000	60,000	—
2002	49,000	42,000	58,000	—
2003	47,000	40,000	55,000	—
2004	46,000	40,000	54,000	—
2005	46,000	41,000	54,000	—
2006	47,000	41,000	54,000	—
2007	47,000	41,000	54,000	—
2008	46,000	40,000	53,000	—
2009	45,000	40,000	52,000	—
2010	45,000	39,000	51,000	4,400
2011	45,000	40,000	52,000	5,800
2012	44,000	39,000	51,000	5,500
2013	43,000	38,000	50,000	6,400
2014	42,000	37,000	49,000	6,900
2015	41,000	36,000	48,000	7,400
2016	40,000	35,000	47,000	8,100
2017	39,000	34,000	46,000	12,000
2018	38,000	33,000	45,000	14,000
2019	38,000	32,000	45,000	15,000
2020	38,000	32,000	45,000	19,000
2021	37,000	31,000	45,000	21,000
2022	37,000	31,000	45,000	25,000
2023	36,000	30,000	45,000	27,000
2024	36,000	30,000	44,000	31,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade

UNAIDS AIDSinfo

Diagnosed
On treatment
Virally suppressed

Year	Diagnosed	On treatment	Virally suppressed
2010	27.0%	10.0%	—
2011	35.0%	13.0%	—
2012	40.0%	12.0%	—
2013	43.0%	15.0%	—
2014	45.0%	16.0%	—
2015	46.0%	18.0%	—
2016	48.0%	20.0%	—
2017	52.0%	30.0%	—
2018	56.0%	36.0%	—
2019	60.0%	41.0%	—
2020	63.0%	49.0%	—
2021	67.0%	57.0%	43.0%
2022	72.0%	67.0%	55.0%
2023	77.0%	73.0%	69.0%
2024	86.0%	86.0%	—

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Data-quality flags on Liberia

Number of people on ART (PEPFAR MER TX_CURR), 2021 (PEPFAR Panorama Spotlight). The value moved from 2,968 in 2020 to 14,813 in 2021, a change of more than threefold in a single year. The move from 2,968 to 14,813 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2020 and 2021 are not comparable. Check the figures by reporting organisation before reading a trend across 2020 and 2021.

People receiving PrEP, 2023 (PEPFAR Panorama Spotlight). The value moved from 1,655 in 2022 to 7,901 in 2023, a change of more than threefold in a single year. The move from 1,655 to 7,901 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2022 and 2023 are not comparable. Check the figures by reporting organisation before reading a trend across 2022 and 2023.

Number of PLHIV virally suppressed (VL<1000), 2021 (PEPFAR Panorama Spotlight). The value moved from 1,671 in 2020 to 7,110 in 2021, a change of more than threefold in a single year. The move from 1,671 to 7,110 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2020 and 2021 are not comparable. Check the figures by reporting organisation before reading a trend across 2020 and 2021.

Sources of the figures for Liberia

3,573 rows

Source	Type	Rows	Indicators	Years	Read from	Retrieved
UNICEF HIV/AIDS dataset	Modelled estimate	1,376	5	2010–2025	sdmx.data.unicef.org	2026-10-20
UNAIDS AIDSinfo	Modelled estimate	591	24	2000–2024	aidsinfo.unaids.org	2026-10-20
UNAIDS HIV sub-national estimates viewer (Naomi)	Modelled estimate	336	7	2025	nmviewerserver.azurewebsites.net	2026-10-14
WHO Global Health Observatory	Modelled estimate	245	12	2000–2025	ghoapi.azureedge.net	2026-10-12
Demographic and Health Surveys	Survey	158	4	2007–2019	api.dhsprogram.com	2026-10-16
PEPFAR results by province	Programme record	149	7	2020–2025	data.pepfar.gov	2026-10-12
WHO Global Tuberculosis Programme	Programme record	129	15	2000–2024	extranet.who.int	2026-10-16
PEPFAR results by funding agency and province	Programme record	71	6	2020–2025	data.pepfar.gov	2026-10-12
ForeignAssistance.gov	Expenditure account	70	5	2006–2026	foreignassistance.gov	2026-10-29
IATI, through d-portal	Expenditure account	65	3	2000–2026	d-portal.org	2026-10-12
Global Fund Data Service	Programme record	62	9	2017–2025	fetch.theglobalfund.org	2026-10-12
OECD Creditor Reporting System	Expenditure account	62	3	2002–2024	sdmx.oecd.org	2026-10-12
World Bank Open Data	Modelled estimate	51	2	2000–2025	api.worldbank.org	2026-10-12
PEPFAR Panorama Spotlight	Programme record	45	9	2020–2025	data.pepfar.gov	2026-10-12
PEPFAR testing by modality	Programme record	32	6	2020–2025	data.pepfar.gov	2026-10-12
PEPFAR budgets and expenditure	Expenditure account	30	6	2021–2025	data.pepfar.gov	2026-10-12
PEPFAR results by funding agency	Programme record	27	6	2020–2025	data.pepfar.gov	2026-10-12
WHO Global Health Expenditure Database	Expenditure account	21	7	2016–2020	apps.who.int	2026-10-12
WHO HIV testing services dashboard	Programme record	21	3	2018–2024	eic-database-290813.ew.r.appspot.com	2026-10-14
UNAIDS Global AIDS Monitoring expenditure database	Expenditure account	17	9	2014–2015	hivfinancial.unaids.org	2026-10-12
Global Fund allocations	Expenditure account	4	1	2017–2026	fetch.theglobalfund.org	2026-10-12
PEPFAR commodity procurement plans	Expenditure account	4	4	2022	data.pepfar.gov	2026-10-12
PEPFAR human resources for health inventory	Expenditure account	3	3	2025	data.pepfar.gov	2026-10-12
PEPFAR operating-unit budgets	Expenditure account	2	2	2020	data.pepfar.gov	2026-10-12
UNAIDS Data 2025 country databook	Expenditure account	2	2	2015	aidsinfo.unaids.org	2026-10-15

Indicators held

96 of 150

Indicator	Domain	Unit	Rows	Years	Sources	Most recent value
Actual expenditure on collaborative TB/HIV activities	Financing	USD	4	2018–2023	WHO Global Tuberculosis Programme	$23k (2023)
Budget required for collaborative TB/HIV activities	Financing	USD	6	2019–2024	WHO Global Tuberculosis Programme	$1.8m (2024)
Country-reported HIV expenditure, all sources	Financing	USD	4	2014–2015	UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database	$10.3m (2015)
Domestic public HIV expenditure	Financing	USD	1	2014	UNAIDS Global AIDS Monitoring expenditure database	$42k (2014)
Expected Global Fund funding for the national TB programme	Financing	USD	7	2018–2024	WHO Global Tuberculosis Programme	$4.4m (2024)
Expected USAID funding for the national TB programme	Financing	USD	6	2018–2023	WHO Global Tuberculosis Programme	$322k (2023)
Expected domestic funding for the national TB programme	Financing	USD	4	2018–2021	WHO Global Tuberculosis Programme	$287k (2021)
Expected funding for collaborative TB/HIV activities	Financing	USD	6	2019–2024	WHO Global Tuberculosis Programme	$300k (2024)
External HIV and STD spending, national health accounts	Financing	USD	3	2016–2020	WHO Global Health Expenditure Database	$8.1m (2020)
External HIV financing (all donors, ODA)	Financing	USD	23	2002–2024	OECD Creditor Reporting System	$24.9m (2024)
External HIV financing from governments other than the United States (IATI)	Financing	USD	27	2000–2026	IATI, through d-portal	$101k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI)	Financing	USD	15	2012–2026	IATI, through d-portal	$20k (2026)
External HIV financing from the United States (ODA)	Financing	USD	40	2006–2026	ForeignAssistance.gov, OECD Creditor Reporting System	$10.0m (2026)
Funding received for collaborative TB/HIV activities	Financing	USD	4	2018–2023	WHO Global Tuberculosis Programme	$23k (2023)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure	Financing	USD per three-year allocation cycle	4	2017–2026	Global Fund allocations	28,883,607 (2026)
Global Fund HIV disbursements to the country	Financing	USD	45	2004–2026	IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database	$9.2m (2026)
Global Fund funding received by the national TB programme	Financing	USD	4	2018–2023	WHO Global Tuberculosis Programme	$1.6m (2023)
Government HIV and STD spending as a share of government health spending	Financing	percent	3	2016–2020	WHO Global Health Expenditure Database	18.2% (2020)
Government HIV and STD spending, national health accounts	Financing	USD	3	2016–2020	WHO Global Health Expenditure Database	$7.3m (2020)
HIV and STD spending as a share of all external health spending	Financing	percent	3	2016–2020	WHO Global Health Expenditure Database	11.4% (2020)
HIV and STD spending as a share of all health spending	Financing	percent	3	2016–2020	WHO Global Health Expenditure Database	6.0% (2020)
HIV and STD spending, national health accounts	Financing	USD	3	2016–2020	WHO Global Health Expenditure Database	$23.6m (2020)
HIV spending on critical enablers	Financing	USD	2	2014–2015	UNAIDS Global AIDS Monitoring expenditure database	$910k (2015)
HIV spending on governance and sustainability	Financing	USD	2	2014–2015	UNAIDS Global AIDS Monitoring expenditure database	$2.7m (2015)
HIV spending on prevention	Financing	USD	2	2014–2015	UNAIDS Global AIDS Monitoring expenditure database	$4.1m (2015)
HIV spending on treatment, care and support	Financing	USD	2	2014–2015	UNAIDS Global AIDS Monitoring expenditure database	$2.6m (2015)
International HIV expenditure (country-reported)	Financing	USD	3	2014–2015	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$10.3m (2015)
PEPFAR expenditure, USAID	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$5.3m (2025)
PEPFAR expenditure, all US agencies	Financing	USD	6	2020–2025	PEPFAR budgets and expenditure, PEPFAR operating-unit budgets	$7.0m (2025)
PEPFAR expenditure, other US agencies	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$1.7m (2025)
PEPFAR planned commodity procurement, like for like	Financing	USD	1	2022	PEPFAR commodity procurement plans	$175k (2022)
PEPFAR planned funding (budget), all US agencies	Financing	USD	6	2020–2025	PEPFAR budgets and expenditure, PEPFAR operating-unit budgets	$9.6m (2025)
PEPFAR planned funding, USAID	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$7.3m (2025)
PEPFAR planned funding, other US agencies	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$2.2m (2025)
PEPFAR planned procurement of antiretroviral drugs	Financing	USD	1	2022	PEPFAR commodity procurement plans	$0 (2022)
PEPFAR planned procurement of laboratory commodities	Financing	USD	1	2022	PEPFAR commodity procurement plans	$0 (2022)
PEPFAR planned procurement of rapid test kits	Financing	USD	1	2022	PEPFAR commodity procurement plans	$0 (2022)
PEPFAR spend on staff, human resources for health inventory	Financing	USD	1	2025	PEPFAR human resources for health inventory	$3.7m (2025)
PEPFAR-funded staff delivering services, full-time equivalents	Financing	count	1	2025	PEPFAR human resources for health inventory	164 (2025)
PEPFAR-funded staff, full-time equivalents	Financing	count	1	2025	PEPFAR human resources for health inventory	271 (2025)
Private HIV and STD spending, national health accounts	Financing	USD	3	2016–2020	WHO Global Health Expenditure Database	$8.3m (2020)
Private HIV expenditure (country-reported)	Financing	USD	3	2014–2015	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$8k (2015)
US HIV disbursements managed by Health and Human Services	Financing	USD	7	2020–2026	ForeignAssistance.gov	$1.1m (2026)
US HIV disbursements managed by USAID	Financing	USD	21	2006–2026	ForeignAssistance.gov	$-6 (2026)
US HIV disbursements managed by other US agencies	Financing	USD	19	2008–2026	ForeignAssistance.gov	$84k (2026)
US HIV disbursements managed by the State Department	Financing	USD	2	2025–2026	ForeignAssistance.gov	$8.8m (2026)
% of ALL PLHIV who are virally suppressed	Treatment cascade	percent	5	2021–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	54.0% (2025)
% of PLHIV on ART (second 95, PLHIV base)	Treatment cascade	percent	115	2000–2025	UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory	59.0% (2025)
% of PLHIV who have been diagnosed (first 95)	Treatment cascade	percent	74	2010–2025	UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory	73.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART	Treatment cascade	percent	17	2008–2024	UNAIDS AIDSinfo	54.1% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	3	2018–2021	UNAIDS AIDSinfo	18.3% (2021)
% of people newly enrolled in HIV treatment diagnosed with TB disease	Treatment cascade	percent	7	2015–2024	UNAIDS AIDSinfo	7.2% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	4	2016–2023	UNAIDS AIDSinfo	53.9% (2023)
% of people on ART who are virally suppressed (third 95)	Treatment cascade	percent	22	2021–2025	PEPFAR results by province, WHO Global Health Observatory	91.0% (2025)
% of returned HIV test results that were positive	Treatment cascade	percent	19	2018–2024	UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	4.2% (2024)
HIV tests performed at a health facility	Treatment cascade	count	9	2018–2025	PEPFAR testing by modality, WHO HIV testing services dashboard	35,524 (2025)
HIV tests performed through community outreach	Treatment cascade	count	4	2021–2024	PEPFAR testing by modality	21,989 (2024)
HIV tests performed with the result returned to the person	Treatment cascade	count	60	2017–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	35,524 (2025)
HIV-exposed infants tested within two months of birth	Treatment cascade	percent	13	2010–2024	UNAIDS AIDSinfo	18.0% (2024)
HIV-positive TB patients started or continued on ART	Treatment cascade	count	19	2015–2025	Global Fund Data Service, WHO Global Tuberculosis Programme	870 (2025)
Key-population people tested for HIV (count over the period)	Treatment cascade	count	3	2021–2023	Global Fund Data Service	By population group, sex or age only, to 2023
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS)	Treatment cascade	count	26	2020–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	1,164 (2025)
Newly diagnosed at other US-agency partners (MER HTS_TST_POS)	Treatment cascade	count	12	2020–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	73 (2025)
Newly enrolled on ART at USAID-funded partners (MER TX_NEW)	Treatment cascade	count	26	2020–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	1,154 (2025)
Newly enrolled on ART at other US-agency partners (MER TX_NEW)	Treatment cascade	count	4	2020–2021	PEPFAR results by funding agency, PEPFAR results by funding agency and province	201 (2021)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)	Treatment cascade	count	36	2020–2025	PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality	1,237 (2025)
Number of PLHIV virally suppressed (VL<1000)	Treatment cascade	count	26	2020–2025	PEPFAR Panorama Spotlight, PEPFAR results by province	15,741 (2025)
Number of people on ART (PEPFAR MER TX_CURR)	Treatment cascade	count	153	2000–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory, WHO Global Tuberculosis Programme	33,301 (2025)
PMTCT ART coverage among pregnant women with HIV	Treatment cascade	percent	31	2010–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset	80.0% (2025)
People living with HIV in care screened for TB	Treatment cascade	count	7	2017–2023	Global Fund Data Service	6,351 (2023)
People living with HIV on ART who started TB preventive therapy	Treatment cascade	count	8	2018–2025	Global Fund Data Service	15,527 (2025)
People newly diagnosed at a health facility	Treatment cascade	count	6	2020–2025	PEPFAR testing by modality	1,237 (2025)
People newly diagnosed through community outreach	Treatment cascade	count	4	2021–2024	PEPFAR testing by modality	1,286 (2024)
People newly enrolled on ART during the year	Treatment cascade	count	35	2015–2025	PEPFAR Panorama Spotlight, PEPFAR results by province, WHO Global Tuberculosis Programme	1,154 (2025)
People on ART at USAID-funded partners (MER TX_CURR)	Treatment cascade	count	26	2020–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	21,347 (2025)
People on ART at other US-agency partners (MER TX_CURR)	Treatment cascade	count	4	2020–2021	PEPFAR results by funding agency, PEPFAR results by funding agency and province	1,099 (2021)
People tested for HIV in the last 12 months who received the result (household survey)	Treatment cascade	percent	38	2007–2019	Demographic and Health Surveys	By population group, sex or age only, to 2019
Pregnant women tested for HIV in antenatal care	Treatment cascade	percent	13	2012–2024	UNAIDS AIDSinfo	98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT	Treatment cascade	count	41	2010–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, UNAIDS AIDSinfo, WHO Global Health Observatory	1,962 (2025)
TB patients recorded as HIV-positive	Treatment cascade	count	15	2015–2025	PEPFAR Panorama Spotlight, WHO Global Tuberculosis Programme	36 (2025)
TB patients with an HIV test result recorded	Treatment cascade	count	24	2015–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, WHO Global Tuberculosis Programme	729 (2025)
AIDS-related deaths	Epidemic estimates	count	681	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	1,400 (2025)
Deaths from TB among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	380 (2024)
HIV prevalence among a key population	Epidemic estimates	percent	3	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
HIV prevalence, ages 15-49	Epidemic estimates	percent	137	2000–2025	Demographic and Health Surveys, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data	1.5% (2025)
Incident TB cases among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	1,200 (2024)
New HIV infections	Epidemic estimates	count	458	2000–2025	UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory	2,900 (2025)
People living with HIV	Epidemic estimates	count	729	2000–2025	UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory	56,000 (2025)
Condom use at last higher-risk sex (household survey)	Prevention and outreach	percent	38	2007–2019	Demographic and Health Surveys	By population group, sex or age only, to 2019
Key-population people reached by outreach (count over the period)	Prevention and outreach	count	3	2021–2023	Global Fund Data Service	By population group, sex or age only, to 2023
People receiving PrEP	Prevention and outreach	count	23	2022–2025	PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo	2,521 (2025)
People with comprehensive correct knowledge of HIV (household survey)	Prevention and outreach	percent	43	2007–2019	Demographic and Health Surveys	By population group, sex or age only, to 2019
Estimated pregnant women with HIV needing ARVs for PMTCT	Population denominators	count	31	2010–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	2,500 (2025)
Estimated size of a key population	Population denominators	count	5	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Total population	Population denominators	count	74	2000–2025	UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data	5,731,206 (2025)
Share of HIV-exposed infants who acquire HIV	—	percent	16	2010–2025	UNICEF HIV/AIDS dataset	14.5% (2025)

Every row shown on the Liberia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.